Poststroke depression
Conditions
Interventions
Exposed group:Oral XingNao JieYu capsules+Conventional western medicine treatment for post-stroke depression
Non-exposed group:Conventional western medicine treatment for post-stroke depression
Sponsors
Affiliated Hospital of Shaanxi University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Meet the Western medical diagnostic criteria for post-stroke depression; (2) Meet the diagnostic criteria of traditional Chinese medicine phlegm and stasis syndrome; (3) Those who are assessed by the HAMD-17 scale and have a score between 7 and 24 points; (4) Age 18-75 years old, no gender limit; (5) Sign the informed consent form, be able to take medication regularly according to the doctor's instructions and follow up regularly.
Exclusion criteria
Exclusion criteria: (1) Previous history of mental illness or family history of mental illness; (2) Patients with severe cardiovascular, hepatic and kidney, hematopoietic system and endocrine immune system diseases; (3) Those with dementia, aphasia, cognitive dysfunction and inability to cooperate with the completion of the scale and other related examinations; (4) Those with a history of drug abuse (including sleeping pills) or alcohol abuse; (5) Those with allergies and allergies to a variety of drugs; (6) Those who are participating in or have participated in other clinical research trials within the past 30 days
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hamilton Depression Scale-17,HAMD-17; | — |
Secondary
| Measure | Time frame |
|---|---|
| Self-rating depression scale,SDS;The World Health Organization Quality of Life,WHOQOL-BREF;NIH Stroke Scale,NIHSS;Traditional Chinese Medicine Syndrome Integral Scale; | — |
Countries
China
Contacts
Public ContactYan Yongmei
Affiliated Hospital of Shaanxi University of Chinese Medicine
Outcome results
None listed